Search research articles
Contact Us
Filters
Showing results (191-200 of 403) with videos related to
Page
of 41
Sort By:
Journal of Autoimmunity
|
January 29, 2013
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B
Stefanie Koristka, Marc Cartellieri, Claudia Arndt, et al.
Experimental Hematology
|
February 5, 2013
Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation
Claudia Ortlepp, Christine Steudel, Caroline Heiderich, et al.
Digestive Diseases and Sciences
|
June 18, 2002
Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives
Stephan Miehlke, Jun Yu, Matthias Ebert, et al.
Cancer Research
|
October 19, 2018
JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Letter
Malte von Bonin, Katharina Moll, Michael Kramer, et al.
Blood
|
May 2, 2015
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug
Martin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, et al.
International Journal of Cancer
|
January 6, 2010
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience
Jacques-Olivier Bay, Aurélie Cabrespine-Faugeras, Reza Tabrizi, et al.
Leukemia Research
|
August 5, 2014
Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays
M Kamran Mirza, Madina Sukhanova, Friedrich Stölzel, et al.
Haematologica
|
March 1, 2002
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease
Johannes Schetelig, Nicolaus Kröger, Thomas K Held, et al.
Current Clinical Pharmacology
|
September 11, 2008
Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients
Stefan Pursche, Eberhard Schleyer, Malte von Bonin, et al.
Leukemia Research
|
August 14, 2009
An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia
Walter Fiedler, Rolf Mesters, Michael Heuser, et al.
Page
of 41
Search research articles
Search
Showing results (191-200 of 403) with videos related to
Sort By:
Page
of 41
Journal of Autoimmunity
|
January 29, 2013
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B
Stefanie Koristka, Marc Cartellieri, Claudia Arndt, et al.
Experimental Hematology
|
February 5, 2013
Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation
Claudia Ortlepp, Christine Steudel, Caroline Heiderich, et al.
Digestive Diseases and Sciences
|
June 18, 2002
Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives
Stephan Miehlke, Jun Yu, Matthias Ebert, et al.
Cancer Research
|
October 19, 2018
JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Letter
Malte von Bonin, Katharina Moll, Michael Kramer, et al.
Blood
|
May 2, 2015
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug
Martin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, et al.
International Journal of Cancer
|
January 6, 2010
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience
Jacques-Olivier Bay, Aurélie Cabrespine-Faugeras, Reza Tabrizi, et al.
Leukemia Research
|
August 5, 2014
Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays
M Kamran Mirza, Madina Sukhanova, Friedrich Stölzel, et al.
Haematologica
|
March 1, 2002
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease
Johannes Schetelig, Nicolaus Kröger, Thomas K Held, et al.
Current Clinical Pharmacology
|
September 11, 2008
Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients
Stefan Pursche, Eberhard Schleyer, Malte von Bonin, et al.
Leukemia Research
|
August 14, 2009
An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia
Walter Fiedler, Rolf Mesters, Michael Heuser, et al.
Page
of 41